Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients

Diabetes and Metabolism

Volumn 32, Issue 4, 2006, Pages 350-357

  Boullu Sanchis, S ^a   Ortega, F ^a   Chabrier, G ^a   Busch, M S ^a   Uhl, C ^a   Pinget, M ^a   Jeandidier, N ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Hospital diabetes management; Insulin infusion; Subcutaneous lispro; Uncontrolled type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN LISPRO; NEUTRAL INSULIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CATHETER COMPLICATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DOWN REGULATION; DRUG EFFICACY; FEMALE; FISHER EXACT TEST; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN INFUSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; WILCOXON SIGNED RANKS TEST;

EID: 33748779044     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70290-2     Document Type: Article

References (20)

1. Clement S, Braithwaite S, Magee M, et al. On behalf of the Diabetes in Hospitals Writing Committee. Management of Diabetes and Hyperglycemia in Hospitals. Diabetes Care 2004;27:553-86.
2. Bloomgarten Z. Patient Diabetes Control: Rationale. Diabetes Care 2004;27:2074-9.
3. American Diabetes Association. Standards of Medical Care in Diabetes Diabetes Care 2005;28S1:S4-S36.
4. Van den Berghe G, Wouters P, Weekers F, et al. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med 2001;345:1359-67.
5. Mao CS, Riegelhuth ME, Van Gundy D, et al. Overnight Insulin Infusion Algorithm Provides Morning Normoglycemia and can be Used to Predict Insulin Requirements in Non Insulindependant Diabetes Mellitus. J Clin Endocrinol Metab 1997;82:2466-70.
6. Metchick LN, Petit WA, Inzucchi SE. Patient Management of Diabetes mellitus. Am J Med 2002;113:317-23.
7. Bregenzer T, Conen D, Sakmann P, et al. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998;158:151-6.
8. Curran ET, Coia JE, Gilmour H, et al. Multi-Center Research Surveillance Project to Reduce Infections/phlebitis associated with Peripheral Vascular Catheters. J Hosp Infect 2000;46:194-202.
9. Hill P, Birch M, Chambers S, et al. Prospective study of 424 cases of Staphylococcus aureus bacterelia: determination of factors affecting incidence and mortality. Int Med J 2001;31:97-103.10.
10. Raskin P, Holcombe JH, Tamborlane WV, et al. Comparison of Insulin Lispro and Buffered Regular Insulin administered via Continuous Subcutaneous Insulin Infusion Pump. J Diabetes Complications 2001;15:295-300.
11. Umpierrez GE, Latif K, Stoever J, et al. Efficacy of Subcutaneous Insulin lispro versus Continuous Intravenous Regular Insulin for the treatment of Patients with Diabetic Ketoacidosis. Am J Med 2004;117:291-6.
12. Furnary AP, Zerr KJ, Grunkemeier GE, et al. Continuous Intravenous Insulin Infusion reduces the Incidence of Deep Sternal Wound Infection in Diabetic Patients after Cardiac Surgical Procedures. Ann Thoracic Surg 1999;67:352-60.
13. Vanhorebeek I, Langouche L, Van den Berghe G. Glycemic and non Glycemic Effects of Insulin: how do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005;11:304-11.
14. Mirouze J, Selam JL, Pham TC, et al. Evaluation of exogenous insulin homeostasis by the artificial pancreas in insulin dependant diabetes. Diabetologia 1977;13:273-8.
15. Skyler JS, Skyler D, Seigler DE, et al. Algorithms for adjustment of insulin dosage by patients who monitor blood glucose. Diabetes Care 1981;4:311-8.
16. Skyler JS, Seigler D, Reeves M. Optimizing pumped insulin delivery. Diabetes Care 1982;5:135-47.
17. Pouwels MJ, Tack CJ, Hermust AR, et al. Treatment with intravenous insulin followed by subcutaneous insulin infusion improves glycaemic control in severely resistant type 2 diabetic patients. Diabet Med 2003;20:76-9.
18. Glaser B, Leibovitch G, Nesher R, et al. Improved betacell function after intensive insulin treatment in severe non insulin dependent diabetes. Acta Endocrinol 1998;118:365-73.
19. Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uncontrolled type 2 diabetes: evaluation of a pragmatic attitude. Diabetes Metab 2000;26:371-5.
20. Mesotten D, Swinnenn J, Vanderhoydonc, et al. Contribution of Circulating Lipids to the Outcome of Critical Illness by Glycemic Control with Intensive Insulin Therapy. J Clin Endocrinol Metab 2004;89:219-26.